CDI(CODX) - 2025 Q1 - Quarterly Results

Exhibit 99.1 Co-Diagnostics, Inc. Reports First Quarter 2025 Financial Results SALT LAKE CITY, May 8, 2025— Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended March 31, 2025. First Quarter 2025 Financial Results: First Quarter Business Highlights: "During the quarter, Co-Diagnostics continued to make significant progress in the development of our test ...